Tag: 180-day exclusivity
Paragraph IV Certifications: How Generic Drug Makers Legally Challenge Pharma Patents
Paragraph IV certifications let generic drug makers legally challenge brand-name patents before launch. This Hatch-Waxman tool saves billions annually and gives the first challenger 180 days of exclusive sales-if they navigate the legal minefield correctly.
Categories
- Health and Medicine (38)
- Medications (36)
- Health and Wellness (34)
- Online Pharmacy Guides (15)
- Nutrition and Supplements (7)
- Parenting and Family (3)
- Environment and Conservation (2)
- healthcare (1)
- prescription savings (1)
